Skip to main content
. 2021 May 1;12(3):409–420. doi: 10.32598/bcn.12.3.2049.1

Table 1.

Demographic and baseline clinical data of the patients with neuropathic pain following spinal cord injury

Age Range (Y) Subject No./Gender TFI 1 Level and/Kind of Injury Symptom Characteristics Background Medications Blood Electrolyte Concentration

K+ Na+ Ca+2 Mg+2
35 Male 4 T6/MVA2 Burning, shooting, pain needles, electric shock Gabapentin, amitriptyline, zolpidem, venlafaxine 3.53 137 8.4 1.82
33 Male 2 C5/C6 Burning, shooting, pin & needles, electric shock, coldness Pregabalin, amitriptyline, zolpidem, venlafaxine, ketorolac 4.51 137 10.5 2.05
34 Male 3 L1/MVA Burning, shooting Gabapentin, amitriptyline 3.6 136 8.9 2
32 Male 4 T6/MVA Burning, shooting, pin & needles, electric shock Gabapentin, venlafaxine 5 142 9 2.5
36 Male 6 T12, L1, L2/Fall Burning, coldness, pin & needles Pregabalin, alprazolam, methadone 3.7 143 9.6 2.1
40 Male 5 T12/Fall Pin & needles, electric shock Gabapentin, amitriptyline 4.1 134 10.1 2.2
43 Male 3 T11, T12/Fall Pin & needles, numbness, coldness Gabapentin 4.56 141.4 10.4 2
50 Male 5 T11/MVA Burning, shooting, pin & needles, electric shock Alprazolam, gabapentin 3.7 137 8.9 2.5
48 Male 3 L1/MVA Burning, shooting, electric shock Celecoxib, gabapentin 3.8 141 9.2 2.2
45 Male 10 T12, L1/Fall Burning, pin & needles Gabapentin, baclofen, amitriptyline, methadone 4.1 140 9.4 2.3
47 Male 6 T12/Fall Burning, shooting, electric shock Gabapentin, baclofen 4.02 140.5 9.2 2.6

TFI: Time From Injury; Time duration after traumatic spinal cord Injury in years; MVA: Motor Vehicle Accidents.